214 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

NEWBRY

Newbury Pharmaceuticals
kr3.06-5.6%-43.3%kr74.2mkr8.00PS3.3xE112.9%n/a

AXSM

Axsome Therapeutics
US$73.68-0.7%-5.5%US$3.6bUS$123.56PS13.9xE65.1%n/a

ZVRA

Zevra Therapeutics
US$5.035.9%18.1%US$215.9mUS$19.00PS7.6xE65.7%n/a

RCEL

AVITA Medical
US$8.71-0.1%-44.6%US$231.2mUS$25.90PS4.5xE62.0%n/a

CLBIO

Corline Biomedical
kr10.05-4.7%-38.7%kr216.0mkr29.00PS7xE114.8%n/a

SPAGO

Spago Nanomedical
kr0.28-20.9%-64.8%kr63.6mn/aPS10.7xE52.1%n/a

ACR

Acrux
AU$0.063-3.1%26.0%AU$18.3mn/aPS1.6xE115.3%0%

XBRANE

Xbrane Biopharma
kr0.19-7.3%-99.8%kr291.2mn/aPS1.2xE93.7%n/a

FOLD

Amicus Therapeutics
US$9.48-9.1%-18.8%US$3.0bUS$18.78PS6.6xE58.3%n/a

APLS

Apellis Pharmaceuticals
US$42.52-10.5%-52.0%US$5.1bUS$80.38PS9.8xE60.4%n/a

300181

Zhejiang Jolly PharmaceuticalLTD
CN¥15.634.8%33.5%CN¥11.0bn/aPE25.6xE22.3%2.9%

OPTN

OptiNose
US$1.1227.6%-43.4%US$117.6mUS$3.75PS1.8xE59.9%n/a

GTHX

G1 Therapeutics
US$4.9812.2%78.5%US$224.3mUS$8.50PS3.1xE48.2%n/a

ALDX

Aldeyra Therapeutics
US$3.94-6.4%-61.9%US$241.8mUS$9.25PB2.1xE61.8%n/a

ACAD

ACADIA Pharmaceuticals
US$15.21-10.9%-28.7%US$2.8bUS$28.22PS3.1xE40.9%n/a

1801

Innovent Biologics
HK$40.55-3.1%4.0%HK$65.8bHK$55.26PS9.8xE51.3%n/a

4597

Solasia Pharma K.K
JP¥27.000%-41.3%JP¥4.9bJP¥100.00PS8xE61.9%n/a

MRNS

Marinus Pharmaceuticals
US$1.39-4.5%-85.0%US$78.6mUS$8.00PS2.7xE59.0%n/a

SPPI

Spectrum Pharmaceuticals
US$1.035.3%17.0%US$209.9mUS$1.26PS8.2xE67.3%n/a

300871

Hvsen Biotechnology
CN¥15.6011.0%-11.9%CN¥2.6bn/aPS2.6xE60.4%1.9%

2160

GNI Group
JP¥2,394.00-1.9%115.3%JP¥119.4bJP¥4,100.00PE14.8xE24.9%n/a

688520

Sinocelltech Group
CN¥50.681.7%-15.8%CN¥22.6bCN¥65.00PS10.4xE119.6%n/a

SENZA

SenzaGen
kr9.5026.3%-23.4%kr229.8mkr17.75PS4.6xE84.0%n/a

OCUP

Ocuphire Pharma
US$1.965.9%-69.1%US$46.9mUS$19.50PS2.6xE9.5%n/a
Page 1 of 9
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.